Centro de Investigación Príncipe Felipe -ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2023

  1. Rapid degeneration of iPSC-derived motor neurons lacking Gdap1 engages a mitochondrial-sustained innate immune response

    Cell Death Discovery, Vol. 9, Núm. 1

2021

  1. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment

    Neurotherapeutics, Vol. 18, Núm. 4, pp. 2565-2578

2018

  1. MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming

    Stem Cell Reports, Vol. 11, Núm. 6, pp. 1479-1492

2017

  1. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene

    Stem Cell Research, Vol. 18, pp. 1-4

2016

  1. Dysfunctional mitochondrial fission impairs cell reprogramming

    Cell Cycle, Vol. 15, Núm. 23, pp. 3240-3250

2006

  1. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs

    Molecular Biology of the Cell, Vol. 17, Núm. 9, pp. 4002-4013

2005

  1. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases

    Journal of Biological Chemistry, Vol. 280, Núm. 32, pp. 28936-28943

  2. Functional definition of relevant epitopes on the tumor suppressor PTEN protein

    Cancer Letters, Vol. 223, Núm. 2, pp. 303-312

2004

  1. Regulation of MAPK cascades by protein tyrosine phosphatases.

    Methods in molecular biology (Clifton, N.J.), Vol. 250, pp. 103-112

2003

  1. A Novel Loss-of-Function Mutation (N48K) in the PTEN Gene in a Spanish Patient with Cowden Disease

    Journal of Investigative Dermatology, Vol. 121, Núm. 6, pp. 1356-1359

  2. Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3. Implications for the control of protein stability and PTEN-protein interactions

    Journal of Biological Chemistry, Vol. 278, Núm. 33, pp. 30652-30660

2001

  1. Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues

    European Journal of Cancer, Vol. 37, Núm. 1, pp. 114-121

  2. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

    Journal of Biological Chemistry, Vol. 276, Núm. 2, pp. 993-998

1999

  1. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase

    Journal of Cell Biology, Vol. 147, Núm. 6, pp. 1129-1135

  2. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm

    Journal of Biological Chemistry, Vol. 274, Núm. 31, pp. 21900-21907